Hi Whytee …. not sure … the results announcement is so poorly presented its hard to make head nor tail of what is going on.
The flavour I get is that the trial was approached with a very confirmatory bias. Surgery is risky and so you need a big benefit to justify it. That benefit is either shown or not at 26 weeks.
Once that failed the exploratory longer follow-up idea comes into play. But the methods / statistical approach is based around the confirmatory model. Taking a slice in time:
At 6 months sig/ns
At 12 months sig/ns
At 18 months sig/ns
etc
The exploratory approach is to fit a curve to the change over time; is there a trend for improvement over time for the treatment groups. And the more time points you have for this the better; particularly when the N is small.
- Forums
- ASX - By Stock
- Ann: NTCELL Parkinsons trial patient data 2 years after implant
Hi Whytee …. not sure … the results announcement is so poorly...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
|
|||||
Last
1.1¢ |
Change
0.001(10.0%) |
Mkt cap ! $18.56M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.0¢ | $2.942K | 271.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 3488858 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 1690169 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 3488858 | 0.010 |
6 | 6046120 | 0.009 |
7 | 1447959 | 0.008 |
7 | 6280009 | 0.007 |
6 | 2493750 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 1690169 | 11 |
0.012 | 871219 | 5 |
0.013 | 854768 | 3 |
0.014 | 668331 | 4 |
0.015 | 882495 | 5 |
Last trade - 14.17pm 01/07/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online